Loading stock data…
YCBD
$0.87+0.00 (+0.14%)
Market ClosedLast close May 1
cbdMD, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
cbdMD, Inc. in the Healthcare sector is trading at $0.87. The stock is currently near its 52-week low of $0.47, remaining 1.1% below its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why YCBD maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 62) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.87
Potential Upside
726.2%
Whystock Fair Value$7.19
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.76M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
1.55
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-25.97%
Volume
Today's trading volume
1.42M
Recent News
cbdMD, Inc. Q1 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q1 2026 earnings call
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...
cbdMD Inc (YCBD) reports significant financial management improvements and strategic acquisitions, despite facing sales and regulatory challenges.
cbdMD Inc (YCBD) Q4 2025 Earnings Call Highlights: Strategic Growth Amidst Regulatory Challenges
cbdMD Inc (YCBD) reports improved financials and strategic expansion plans, despite a slight dip in annual sales and ongoing regulatory hurdles.
Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session
(Corrects the third paragraph to note the personal income and outlays report being rescheduled.)
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
US stocks look set to open little changed Friday's trading session as investors look ahead to econom